Share-based payments to employees

Share-based payment plans for store managers and executives are a real, often material, non-cash expense that many retailers underplay because no cash changes hands at grant date. Under IFRS 2, the accounting treatment diverges sharply depending on whether the plan is equity-settled (fixed grant-date fair value spread over vesting, never remeasured for share price moves) or cash-settled (remeasured to fair value every period through profit or loss, creating earnings volatility). Getting the classification wrong misstates both the expense pattern and the balance sheet (equity reserve vs liability), and retailers with large field-manager populations can have thousands of grants with different vesting conditions to track. Because the expense is recognized over the vesting period regardless of whether options are ever exercised (for market conditions) or only if service/performance conditions are met (for non-market conditions), forfeitures and condition types must be actively monitored, not set-and-forget at grant date.

Is the plan settled by issuing the entity's own equity instruments (equity-settled, measured once at grant date) or in cash based on a share-price-linked formula (cash-settled, remeasured each period)? What vesting conditions apply, service-only versus performance-based, and how do they affect the expense recognition pattern? Is there a market condition (e.g., a share-price target) embedded in the award that must be reflected in the grant-date fair value rather than in the vesting estimate?

1. Classify the plan at grant date as equity-settled (entity settles by issuing its own equity instruments) or cash-settled (entity settles in cash based on share price, e.g., phantom shares/SARs) - this classification drives the entire subsequent accounting.
2. Identify the vesting conditions attached: service conditions (time-based), performance conditions (market-based, e.g., share price target, or non-market-based, e.g., revenue/EBITDA target), and determine the requisite service/vesting period over which expense will be spread.
3. For equity-settled awards, recognize compensation expense on a straight-line (or graded, if applicable) basis over the vesting period, with a corresponding credit to an equity reserve (share option reserve), based on the estimated number of instruments expected to vest.
4. Re-estimate at each reporting date the number of awards expected to vest based on non-market performance and service conditions only (forfeitures due to failing market conditions or share price targets are NOT reversed - the grant-date fair value already reflects that probability); true up the cumulative expense to date for changes in estimated forfeitures.
5. For cash-settled awards, remeasure the liability to fair value at each reporting date and at settlement, recognizing the change in profit or loss, with the liability building up over the vesting period based on days elapsed and current fair value.
6. On vesting/exercise (equity-settled), transfer the accumulated equity reserve to share capital/share premium (or leave in a separate reserve per policy) with no further P&L impact; on settlement (cash-settled), derecognize the liability against cash paid.

Equity-settled awards are measured ONCE at grant-date fair value using an appropriate option-pricing model (e.g., Black-Scholes, binomial, or Monte Carlo for market-condition awards) and never remeasured thereafter for changes in share price or volatility - only the number of awards expected to vest is updated for non-market conditions. Cash-settled awards are measured at fair value at grant date and remeasured to fair value at every reporting date and at settlement date, with fair value changes recognized immediately in profit or loss (this creates a liability that fluctuates with the underlying share price). For both types, the cumulative expense at any point equals fair value x (awards expected to vest / total awards granted) x (time elapsed / total vesting period), adjusted for actual forfeitures of service/performance conditions.

Disclose: a description of each type of share-based payment arrangement (eligible employees, vesting conditions, maximum term, settlement method - equity or cash); the number and weighted-average exercise price of options outstanding at the beginning and end of the period, granted, forfeited, exercised, and expired during the period; the weighted-average share price at exercise date for options exercised during the period; the weighted-average remaining contractual life for options outstanding at period end; the inputs used to measure grant-date fair value (option-pricing model, expected volatility, risk-free rate, expected life, dividend yield); total expense recognized in the period arising from equity-settled and cash-settled transactions separately; the carrying amount of liabilities arising from cash-settled transactions at period end and their intrinsic value.

• Remeasuring equity-settled awards for subsequent share price movements as if they were cash-settled (grant-date fair value is fixed for equity-settled awards)
• reversing previously recognized expense when options lapse unexercised due to a failed market condition (this should NOT be reversed, unlike failure of service/non-market performance conditions)
• failing to true up the cumulative expense for changes in the estimated number of awards expected to vest each period
• using intrinsic value instead of a proper option-pricing model fair value at grant date without a valid reason
• misclassifying phantom share/SAR plans as equity-settled when they are actually cash-settled because settlement is in cash based on share price
• ignoring graded vesting (tranches vesting at different dates) and expensing on a simple straight-line basis when tranches should be treated as separate grants.